These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2672261)

  • 1. The new quinolones: back to the future.
    Davies J
    Rev Infect Dis; 1989; 11 Suppl 5():S898-901. PubMed ID: 2672261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of quinolones in pediatric patients.
    Adam D
    Rev Infect Dis; 1989; 11 Suppl 5():S1113-6. PubMed ID: 2672245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of quinolone antibacterials.
    Fort FL
    Drug Saf; 1992; 7(3):214-22. PubMed ID: 1503668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The place of quinolones in bacterial infections.
    Neu HC
    Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New quinolones in clinical practice.
    Gould IM
    Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10419336
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk/benefit analysis of quinolone use in children: the effect on diarthrodial joints.
    Maggiolo F; Caprioli S; Suter F
    J Antimicrob Chemother; 1990 Oct; 26(4):469-71. PubMed ID: 2254219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
    Obana M; Matsuoka Y; Irimajiri S; Tonooka H
    Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of the new quinolones: new data.
    Hooper DC; Wolfson JS
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):223-31. PubMed ID: 1650698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone antibiotics in the treatment of Salmonella infections.
    Asperilla MO; Smego RA; Scott LK
    Rev Infect Dis; 1990; 12(5):873-89. PubMed ID: 2237130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of the quinolones.
    Andriole VT
    Drugs; 1999; 58 Suppl 2():1-5. PubMed ID: 10553697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arthrotoxicity of quinolones and fluoroquinolones in experiment:character of lesion and mechanism of action].
    Padeĭskaia EN
    Antibiot Khimioter; 2000; 45(8):36-41. PubMed ID: 10989723
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinolone antimicrobial agents: structure-activity relationships.
    Zhang MQ; Haemers A
    Pharmazie; 1991 Oct; 46(10):687-700. PubMed ID: 1803382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoroquinolones and their importance in modern chemotherapy of infectious diseases].
    Padeĭskaia EN
    Antibiot Khimioter; 1989 Jul; 34(7):514-21. PubMed ID: 2818083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quinolone antibiotics.
    Saravanos K; Duff P
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):529-37. PubMed ID: 1436930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
    Anderson VE; Osheroff N
    Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.